Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease Jardiance® (empagliflozin) now approved in India
Back to life Back to life Anna Higgs had a severe stroke at the age of 24. For years she has been struggling with the consequences. Click here to learn more about her story.
Ethical Business Practices Ethical Business Practices Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.